4,817 results on '"Pfizer Inc. -- Reports"'
Search Results
2. New Clinical Trial Research Findings from Baylor University College of Medicine Outlined (What Is In a Name: Defining Pediatric Refractory Itp)
3. Studies in the Area of Chronic Myeloid Leukemia Reported from Saga University (Targeting Oxidative Phosphorylation with a Novel Thiophene Carboxamide Increases the Efficacy of Imatinib against Leukemic Stem Cells in Chronic Myeloid Leukemia)
4. Recent Findings in Colon Cancer Described by a Researcher from Odette Cancer Centre (Cost-effectiveness analysis of bevacizumab biosimilars for metastatic colorectal cancer: A comparative study using real-world data)
5. Study Results from MedStar Georgetown University Hospital Provide New Insights into Prostate Cancer (Patient Preferences for Attributes of Androgen Deprivation Therapies In Prostate Cancer: a Discrete Choice Experiment With Latent Class Analysis)
6. Research and Markets Brings Out Report: The Corporate Reputation of Pharma in the UK: Survey Results from 87 UK Patient Groups
7. Studies from Washington University Add New Findings in the Area of Artificial Intelligence (Artificial Intelligence for Cardiovascular Care-part 1: Advances)
8. Researchers at Pfizer Report New Data on Solid Cancer (Evaluation of the Effect of Modafinil On the Pharmacokinetics of Encorafenib and Binimetinib In Patients With Braf V600-mutant Advanced Solid Tumors)
9. National Cancer Center Hospital Researcher Provides New Study Findings on Cancer (Clinical landscape of precision oncology for rare cancers among diverse Asian populations: Insights from the MASTER KEY registry)
10. Findings from Pfizer Worldwide Research and Development Provide New Insights into Drug Delivery Systems (Topical Drug Delivery By Sepineo P600 Emulgel: Relationship Between Rheology, Physical Stability, and Formulation Performance)
11. Findings from Pfizer Provide New Insights into Drug Research (Simulating Healthy Participant Pharmacokinetics for Renal and Hepatic Impairment Studies: Retrospective Assessment of the Approach)
12. Few Receive Meds for Opioid Use Disorder After Nonfatal Overdose
13. Investigators at Pfizer Report Findings in Immunoglobulins (Anti-drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route)
14. 2023 Pipeline Report
15. Research on Life Sciences Published by Researchers at Pfizer Inc. (Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development [version 1; peer review: 1 ...)
16. Atopic Dermatitis Negatively Impacts Mental Health
17. Studies from Brigham and Women's Hospital Provide New Data on Post-Operative Pain (Procedure-specific Postoperative Pain Management Guideline for Laparoscopic Colorectal Surgery a Systematic Review With Recommendations for Postoperative Pain ...)
18. Study Findings on Medicinal Chemistry Are Outlined in Reports from Pfizer Research and Development [Chemical Tools for the Gid4 Subunit of the Human E3 Ligase C-terminal To Lish (Ctlh) Degradation Complex]
19. Reports Summarize Obesity, Fitness and Wellness Findings from Pfizer Research and Development (Early Process Development of Two Vanin-1 Inhibitors: Solid Form Challenges and Control of Ambident Reactivity)
20. Wakayama Medical University Researchers Provide New Insights into Kinase Inhibitors (Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced NSCLC-A Brief Report From the CROWN Study)
21. New Findings from Pfizer Inc. in the Area of Apoptosis Reported (Comparative Analysis of Micronucleus Induction and Dna Damage Biomarkers In Tk6 and A375 Cells Using Flow Cytometry)
22. FORM 8-K: PFIZER INC Files Current Report (Oct 29, 2024)
23. Heart Failure Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
24. FORM 8-K: PFIZER INC Files Current Report (Oct 15, 2024)
25. Metastatic Castration-Sensitive Prostate Cancer Clinical Trial Pipeline Insights Featuring 35+ Companies | DelveInsight
26. Metastatic Castration-Sensitive Prostate Cancer Clinical Trial Pipeline Insights Featuring 35+ Companies | DelveInsight
27. Metastatic Colorectal Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
28. Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
29. 'WEEKEND WARRIORS' CAN CUT RISK OF 264 DISEASES
30. Pfizer Invited Public to View and Listen to Webcast of October 29 Conference Call with Analysts
31. Psychedelic Therapeutics Clinical Trials Research Report 2024 Featuring Yale University, Johnson & Johnson, Shire Pharmaceuticals, Pfizer, Lykos, and UCB
32. CDC STUDY FINDS RSV VACCINES PROTECT OLDER ADULTS FROM HOSPITALIZATION
33. NEW RSV VACCINE FOR OLDER ADULTS CAN RESULT IN INDIVIDUAL AND SOCIETAL COST SAVINGS, BENEFITS
34. New RSV vaccine for older adults can result in individual and societal cost savings, benefits
35. Nine in 10 top global companies failing to uphold human rights, report says
36. Combined Covid and flu jab could be available for use on NHS this year; A combined flu and Covid-19 vaccine from Moderna has shown a higher immune response compared with separate single jabs, according to new data from the firm
37. Research from Pfizer Provides New Data on Pharmacy (The Impact of Formulation on Dissolution Coning: Supporting Development of a Classification System and Predictive Tool)
38. Pfizer Researchers Report Recent Findings in Pharmacy (Evaluation of Powder Flow Prediction by Ring Shear Testing at Low Consolidation Stresses)
39. Centre of Postgraduate Medical Education Researchers Detail New Studies and Findings in the Area of Pituitary Cancer (Pathologic Characteristics of Somatotroph Pituitary Tumors-An Observational Single-Center Study)
40. Researchers from Pfizer Detail Findings in Obesity, Fitness and Wellness [Pharmaceutical Forced Degradation (Stress Testing) Endpoints: a Scientific Rationale and Industry Perspective]
41. New Findings from Worldwide Research in the Area of COVID-19 Published (Dosing recommendation of nirmatrelvir/ritonavir using an integrated population pharmacokinetic analysis)
42. Researchers from Pfizer Detail Findings in Gene Therapy (Practical and Statistical Considerations for the Long Term Follow-up of Gene Therapy Trial Participants)
43. New Neoplasms Findings from AstraZeneca Described (Uncovering Variable Neoplasms Between atm Protein-truncating and Common Missense Variants Using 394 694 Uk Biobank Exomes)
44. New Antivirals Study Findings Have Been Reported from Pfizer (Physiologically Based Pharmacokinetic Modeling of the Drug-drug Interaction Between Cyp3a4 Substrate Glasdegib and Moderate Cyp3a4 Inducers In Lieu of a Clinical Study)
45. Researcher at Pfizer Inc. Has Published New Study Findings on Conjugate Vaccines (Burden of Pneumococcal Disease in Young Children Due to Serotypes Contained in Different Pneumococcal Conjugate Vaccines in Eight Asian Countries and Territories)
46. Studies from Pfizer in the Area of Pharmacometrics and Systems Pharmacology Described (Pk/pd Model-informed Dose Selection for Oncology Phase I Expansion: Case Study Based On Pf-06939999, a Prmt5 Inhibitor)
47. New COVID-19 Study Findings Have Been Reported from University of Ottawa (Short- and Long-term Outcomes of Cardiac Adverse Events Following Covid-19 Immunization Managed In a Canadian Pediatric Center)
48. New Cancer Study Findings Have Been Reported by Researchers at Pfizer (Identifying and Addressing the Needs of Caregivers of Patients With Cancer: Evidence On Interventions and the Role of Patient Advocacy Groups)
49. Pfizer Inc. Files SEC Form 8-K, Current Report: (Oct. 15, 2024)
50. Data on Psoriasis Detailed by a Researcher at University of California San Francisco (UCSF) (Tackling Multiple Biologic Failure in Psoriasis: Research and Advocacy Perspectives)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.